All In Biotech

Drug Trial Radar · NCT06869850

Milk Fat Globule Membrane-Enhanced RUTF for Children With Severe Acute Malnutrition

MFGM-EnhaNceD RUTF for Children With SAM

Last checked: Nov 19, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 1,600 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

1,600

Planned (sponsor's estimate)

Start

Sep 22, 2025

Primary completion

Dec 1, 2027

Study completion Dec 1, 2027

Sponsor

Lead sponsor
Washington University School of MedicineAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Project Peanut Butter; Ministry of Health and Sanitation, Sierra Leone; Arla Foods; The Danish Dairy Research Foundation, Denmark
First posted
Mar 11, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Triple (care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 6 months, up to 59 months
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to test the use of milk fat globule membrane (MFGM) in ready-to-use therapeutic food (RUTF) in children with severe acute malnutrition in Sierra Leone. The main questions it aims to answer are: * Will the inclusion of MFGM in RUTF for 6-59-month-old Sierra Leonean children with severe acute malnutrition improve their neurodevelopment? * Will the inclusion of MFGM in RUTF for 6-59-month-old Sierra Leonean children with severe acute malnutrition reduce its worst consequences: death, hospitalization, and remaining severely malnourished despite treatment? Researchers will compare the MFGM-containing RUTF to standard RUTF, which contains skim milk powder. Participants will: * undergo measurement of length, weight, mid-upper arm circumference, and nutritional edema assessment every two weeks during severe malnutrition treatment * be treated with either MFGM-RUTF or standard RUTF at a dose of 2 sachets per day for up to 12 weeks * undergo neurodevelopmental testing using the Malawi Developmental Assessment Tool at the end of SAM treatment and 6 months later * a subset of participants will undergo blood spot collection and stool sample collection

Conditions

  • Severe Acute Malnutrition
  • Cognitive Impairment
  • Kwashiorkor
  • Severe Wasting

Interventions

  • MFGM-RUTF (milk fat globule membrane ready-to-use therapeutic food)Dietary supplement

    MFGM whey protein/fat concentrate powder used in place of skim milk powder in peanut paste-based ready-to-use therapeutic food meeting Codex Alimentarius specifications. There will be 10g of MFGM-containing whey protein/fat concentrate powder per 100g of MFGM-RUTF. Other ingredients and amounts per 100g: 9.5g rice flour, 5g whey permeate, 18.5g palm oil, 31g peanut paste, 22.1g sugar, 2.9g micronutrient mix, 1g fish oil.

  • S-RUTF (standard ready-to-use therapeutic food)Dietary supplement

    Standard peanut paste-based ready-to-use therapeutic food made with skim milk powder meeting Codex Alimentarius specifications. This RUTF is modeled on the most widely used recipe worldwide, containing per 100g: 19.5g skim milk powder, 9.3g palm oil, 7g canola oil, 31.3g peanut paste, 28g sugar, 1g soy flakes, 1g hydrogenated vegetable oil, and 2.9g micronutrient mix.

  • AmoxicillinDrug

    Oral amoxicillin tablets twice per day for 7 days dosed based on weight

  • Sulfadoxine (250 mg)/Pyrimethamine (12.5 mg)Drug

    Malaria chemoprophylaxis, dosed by weight, to be given every month during SAM treatment

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Malawi Developmental Assessment Tool global z-scoreTime frame: 6 (5-7) months after SAM treatment completion
  2. Composite of poor severe acute malnutrition treatment outcomesTime frame: 2-12 weeks of therapeutic feeding

Locations

10 sites in 1 country. Site status is shown where the registry gives one.

  • Bandajuma

    Bandajuma, Pujehun, Sierra Leone

  • Bandasuma

    Bandasuma, Pujehun, Sierra Leone

  • Bendu Malen

    Bendu Malen, Pujehun, Sierra Leone

  • Gbondapi

    Gbondapi, Pujehun, Sierra Leone

  • Jendema

    Jendema, Pujehun, Sierra Leone

  • Potoru

    Potoru, Pujehun, Sierra Leone

  • Static

    Pujehun, Pujehun, Sierra Leone

  • Sahn Malen

    Sahn Malen, Pujehun, Sierra Leone

  • Taninahun

    Taninahun, Pujehun, Sierra Leone

  • Zimmi

    Zimmi, Pujehun, Sierra Leone

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.